Vital Therapies reported $-0.72 in EPS Earnings Per Share for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Biomarin Pharmaceutical BMRN:US $ 0.15 0.48
Dynavax Technologies DVAX:US 0.87 0.65
Enanta Pharmaceuticals ENTA:US -1.53 0.1
Epizyme EPZM:US -0.21 0.17
Insmed INSM:US -0.8 0
Intercept Pharmaceuticals ICPT:US $ -0.25 0.33
Mirati Therapeutics MRTX:US -3.18 0.22
Omeros OMER:US -0.49 0.04
Orasure Technologies OSUR:US -0.26 0.02
Quidel QDEL:US 0.36 10.95
Regulus Therapeutics RGLS:US -0.5 0
Revance Therapeutics RVNC:US -0.88 0.06
Ultragenyx Pharmaceutical RARE:US $ -2.26 0.07
United Therapeutics UTHR:US $ 2.41 2.62
Vital Therapies VTL:US $ -0.72 0.02
Xoma XOMA:US -0.53 0.21